These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32383815)

  • 21. Pediatric Soft Tissue Tumors With BCOR ITD Express EGFR but Not OLIG2.
    Salgado CM; Zin A; Garrido M; Kletskaya I; DeVito R; Reyes-Múgica M; Bisogno G; Donofrio V; Alaggio R
    Pediatr Dev Pathol; 2020; 23(6):424-430. PubMed ID: 32790583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.
    Paret C; Russo A; Otto H; Mayer A; Zahnreich S; Wagner W; Samuel D; Scharnhorst D; Solomon DA; Dhall G; Wong K; Bender H; Alt F; Wingerter A; Neu MA; Beck O; Prawitt D; Eder S; Henninger N; El Malki K; Lehmann N; Backes N; Roth L; Seidmann L; Sommer C; Brockmann MA; Staatz G; Schmidberger H; Faber J
    Oncotarget; 2017 Dec; 8(69):114210-114225. PubMed ID: 29371980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment response of CNS high-grade neuroepithelial tumors with MN1 alteration.
    Baroni LV; Rugilo C; Lubieniecki F; Sampor C; Freytes C; Nobre L; Hansford JR; Malalasekera VS; Zapotocky M; Dodgshun A; Martinez OC; La Madrid AM; Lavarino C; Suñol M; Rutkowski S; Schuller U; Bouffet E; Ramaswamy V; Alderete D
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28627. PubMed ID: 32959992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging Features with Histopathologic Correlation of CNS High-Grade Neuroepithelial Tumors with a
    Cardoen L; Tauziède-Espariat A; Dangouloff-Ros V; Moalla S; Nicolas N; Roux CJ; Bouchoucha Y; Bourdeaut F; Beccaria K; Bolle S; Pierron G; Dufour C; Doz F; Boddaert N; Brisse HJ
    AJNR Am J Neuroradiol; 2022 Jan; 43(1):151-156. PubMed ID: 34887247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central Nervous System Tumor With BCL6 Corepressor Internal Tandem Duplication: Treatment Course of a Long-term Survivor.
    Bakkar M; Altinok D; Kupsky WJ; Marupudi NI; Chiang J; Gorsi HS
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):352-355. PubMed ID: 37314948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets.
    Nakata S; Yuan M; Rubens JA; Kahlert UD; Maciaczyk J; Raabe EH; Eberhart CG
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
    Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
    Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCOR involvement in cancer.
    Astolfi A; Fiore M; Melchionda F; Indio V; Bertuccio SN; Pession A
    Epigenomics; 2019 May; 11(7):835-855. PubMed ID: 31150281
    [No Abstract]   [Full Text] [Related]  

  • 29. CNS tumor with BCOR internal tandem duplication: Clinicopathologic, molecular characteristics and prognosis factors.
    Wang R; Guan W; Qiao M; Zhang Y; Zhang M; Wang K; Wang Y; Wang L
    Pathol Res Pract; 2022 Aug; 236():153995. PubMed ID: 35809497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric BCOR-Altered Tumors From Soft Tissue/Kidney Display Specific DNA Methylation Profiles.
    Salgado CM; Alaggio R; Ciolfi A; Zin A; Diomedi Camassei F; Pedace L; Milano GM; Serra A; Di Giannatale A; Mastronuzzi A; Gianatti A; Bisogno G; Ferrari A; Tartaglia M; Reyes-Múgica M; Locatelli F; Miele E
    Mod Pathol; 2023 Feb; 36(2):100039. PubMed ID: 36853789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'Enfant.
    Cohen-Gogo S; Cellier C; Coindre JM; Mosseri V; Pierron G; Guillemet C; Italiano A; Brugières L; Orbach D; Laurence V; Delattre O; Michon J
    Pediatr Blood Cancer; 2014 Dec; 61(12):2191-8. PubMed ID: 25176412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.
    Lehman NL; Usubalieva A; Lin T; Allen SJ; Tran QT; Mobley BC; McLendon RE; Schniederjan MJ; Georgescu MM; Couce M; Dulai MS; Raisanen JM; Al Abbadi M; Palmer CA; Hattab EM; Orr BA
    Acta Neuropathol Commun; 2019 Mar; 7(1):42. PubMed ID: 30876455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma.
    Kang JH; Lee SH; Lee J; Choi M; Cho J; Kim SJ; Kim WS; Ko YH; Yoo HY
    BMC Cancer; 2021 Jan; 21(1):82. PubMed ID: 33468080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation.
    Nakata S; Arai Y; Fukuoka K; Shirakura T; Yamazaki A; Osawa S; Hama N; Shibata T; Miyagishima T; Horiguchi K; Tosaka M; Yokoo H; Yoshimoto Y; Nobusawa S
    Brain Tumor Pathol; 2024 Jan; 41(1):35-39. PubMed ID: 38133797
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful Treatment of Recurrent Primitive Myxoid Mesenchymal Tumor of Infancy With
    Cramer SL; Li R; Ali S; Bradley JA; Kim HK; Pressey JG
    J Natl Compr Canc Netw; 2017 Jul; 15(7):868-871. PubMed ID: 28687574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.
    Terada K; Yamaguchi H; Ueki T; Usuki K; Kobayashi Y; Tajika K; Gomi S; Kurosawa S; Saito R; Furuta Y; Miyadera K; Tokura T; Marumo A; Omori I; Sakaguchi M; Fujiwara Y; Yui S; Ryotokuji T; Arai K; Kitano T; Wakita S; Fukuda T; Inokuchi K
    Genes Chromosomes Cancer; 2018 Aug; 57(8):401-408. PubMed ID: 29663558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gliomatosis cerebri: molecular pathology and clinical course.
    Herrlinger U; Felsberg J; Küker W; Bornemann A; Plasswilm L; Knobbe CB; Strik H; Wick W; Meyermann R; Dichgans J; Bamberg M; Reifenberger G; Weller M
    Ann Neurol; 2002 Oct; 52(4):390-9. PubMed ID: 12325066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney.
    Han H; Bertrand KC; Patel KR; Fisher KE; Roy A; Muscal JA; Venkatramani R
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28151. PubMed ID: 31876361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene of the month: BCOR.
    Aldera AP; Govender D
    J Clin Pathol; 2020 Jun; 73(6):314-317. PubMed ID: 32161069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A polyphenotypic malignant paediatric brain tumour presenting a MN1-PATZ1 fusion, no epigenetic similarities with CNS High-Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET-MN1) and related to PATZ1-fused sarcomas.
    Burel-Vandenbos F; Pierron G; Thomas C; Reynaud S; Gregoire V; Duhil de Benaze G; Croze S; Chivoret N; Honavar M; Figarella-Branger D; Maurage CA; Pedeutour F; Hasselblatt M; Godfraind C
    Neuropathol Appl Neurobiol; 2020 Aug; 46(5):506-509. PubMed ID: 32397004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.